Reported Friday, Allergan Aesthetics, An Abbvie Company, Announces FDA Approval Of BOTOX Cosmetic For Moderate To Severe Vertical Bands Connecting The Jaw And Neck
Portfolio Pulse from Benzinga Newsdesk
Allergan Aesthetics, a subsidiary of AbbVie, has received FDA approval for BOTOX Cosmetic to treat moderate to severe vertical bands connecting the jaw and neck. This makes BOTOX the only product approved for four aesthetic indications.
October 21, 2024 | 8:11 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AbbVie's subsidiary, Allergan Aesthetics, has received FDA approval for BOTOX Cosmetic to treat vertical bands between the jaw and neck, expanding its market potential.
The FDA approval allows BOTOX Cosmetic to be used for a new indication, potentially increasing its market share and revenue for AbbVie. This is a positive development for the company, likely to boost investor sentiment.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90